BGI
REPL icon

B Group Inc’s Replimune Group REPL Stock Holding History

B Group Inc’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,000
Closed -$199K – 21
2026
Q1 		$199K Buy
+26,000
New +$199K 0.15% 20

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

B Group Inc's REPL Position: Q2 2026 in Review

B Group Inc sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 26,000 shares — an estimated $199K sold.

B Group Inc first reported a position in REPL in Q1 2026 and held it in 1 quarter. The position peaked at $199K in Q1 2026. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • B Group Inc reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • B Group Inc sold 26,000 Replimune Group shares in Q2 2026, an estimated $199K.
  • B Group Inc first reported a position in Replimune Group in Q1 2026 and held it in 1 quarter.
  • B Group Inc's Replimune Group position peaked at $199K in Q1 2026.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on B Group Inc's 13F filing for Q2 2026, filed 14 Aug 2026.